Home | Business News | Browse by Publication | H | Harvard Health Letter

Changing the cardiovascular prevention game.

Publication: Harvard Health Letter
Publication Date: 01-JAN-09
Format: Online
Delivery: Immediate Online Access

Article Excerpt
Changing the cardiovascular prevention game

Results from a large clinical trial may mean a new era of super-low LDL targets and anti-inflammatory strategies.

Commentators on the presidential debates in the fall of 2008 were often asked whether they had spotted any "game changers" * something the candidates said or did that would alter the course of the election. A few days after Election Day, many doctors (especially cardiologists) were talking about a game changer in how we go about preventing heart attacks and strokes.

They were reacting to results from a large clinical trial that showed cardiovascular events were cut in half by taking a powerful statin drug among people whose "bad" LDL cholesterol levels were fine, according to current guidelines, and in no need of lowering. What's more,...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Harvard Health Letter
12 ways to cut health care costs., March 01, 2009

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.